开放知识产权平台对生命科学知识产权战略规范的影响

Q3 Decision Sciences

International Journal of Technology Intelligence and Planning Pub Date : 2012-06-18 DOI:10.1504/IJTIP.2012.047378

Tobias Thornblad, T. Hedner

{"title":"开放知识产权平台对生命科学知识产权战略规范的影响","authors":"Tobias Thornblad, T. Hedner","doi":"10.1504/IJTIP.2012.047378","DOIUrl":null,"url":null,"abstract":"In the biomedical fi eld multiple stakeholders may collaboratively develop, package and build transactions around technology. This is often referred to as open innovation, open biotechnology or open source R&D. Intellectual Property (IP) and IP rights play important roles in collaborative platforms but little research has previously assessed the impact that such platforms exert on corporate IP-strategies. A case study was therefore conducted of the Innovative Medicines Initiative (IMI), CAMBIA Biological Open Source (BiOS) and the Medicines for Malaria Venture (MMV). Our results impact managerial decision-makers at pharmaceutical, biotech and agriscience companies intending to implement corporate open innovation and IP strategies.","PeriodicalId":52540,"journal":{"name":"International Journal of Technology Intelligence and Planning","volume":"43 1","pages":"60"},"PeriodicalIF":0.0000,"publicationDate":"2012-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"The impact of open IP platforms on IP-strategy norms in Life Sciences\",\"authors\":\"Tobias Thornblad, T. Hedner\",\"doi\":\"10.1504/IJTIP.2012.047378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the biomedical fi eld multiple stakeholders may collaboratively develop, package and build transactions around technology. This is often referred to as open innovation, open biotechnology or open source R&D. Intellectual Property (IP) and IP rights play important roles in collaborative platforms but little research has previously assessed the impact that such platforms exert on corporate IP-strategies. A case study was therefore conducted of the Innovative Medicines Initiative (IMI), CAMBIA Biological Open Source (BiOS) and the Medicines for Malaria Venture (MMV). Our results impact managerial decision-makers at pharmaceutical, biotech and agriscience companies intending to implement corporate open innovation and IP strategies.\",\"PeriodicalId\":52540,\"journal\":{\"name\":\"International Journal of Technology Intelligence and Planning\",\"volume\":\"43 1\",\"pages\":\"60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Technology Intelligence and Planning\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1504/IJTIP.2012.047378\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Decision Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Intelligence and Planning","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1504/IJTIP.2012.047378","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Decision Sciences","Score":null,"Total":0}

引用次数: 3

摘要

在生物医学领域，多个利益相关者可以围绕技术协作开发、打包和构建交易。这通常被称为开放式创新、开放式生物技术或开源研发。知识产权(IP)和知识产权在合作平台中发挥着重要作用，但之前很少有研究评估这些平台对企业知识产权战略的影响。因此，对创新药物倡议(IMI)、CAMBIA生物开源项目(BiOS)和疟疾药物项目(MMV)进行了案例研究。我们的研究结果影响了制药、生物技术和农业科学公司的管理决策者，他们打算实施企业开放式创新和知识产权战略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The impact of open IP platforms on IP-strategy norms in Life Sciences

In the biomedical fi eld multiple stakeholders may collaboratively develop, package and build transactions around technology. This is often referred to as open innovation, open biotechnology or open source R&D. Intellectual Property (IP) and IP rights play important roles in collaborative platforms but little research has previously assessed the impact that such platforms exert on corporate IP-strategies. A case study was therefore conducted of the Innovative Medicines Initiative (IMI), CAMBIA Biological Open Source (BiOS) and the Medicines for Malaria Venture (MMV). Our results impact managerial decision-makers at pharmaceutical, biotech and agriscience companies intending to implement corporate open innovation and IP strategies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Technology Intelligence and Planning Business, Management and Accounting-Management of Technology and Innovation

CiteScore

3.20

自引率

0.00%

发文量

期刊介绍： The IJTIP is a refereed journal that provides an authoritative source of information in the field of technology intelligence, technology planning, R&D resource allocation, technology controlling, technology decision-making processes and related disciplines.